Your institution may have access to this item. Find your institution then sign in to continue.
Title
Ankylosing spondylitis: what is the optimum duration of a clinical study? A one year versus a 6 weeks non-steroidal anti-inflammatory drug trial.
Authors
Dougados, M; Gueguen, A; Nakache, J P; Velicitat, P; Veys, E M; Zeidler, H; Calin, A
Abstract
To consider the relevance of the duration of a clinical trial in ankylosing spondylitis: long-term (i.e. 1 yr) vs short-term (i.e. 6 weeks) assessment of a non-steroidal anti-inflammatory drug (NSAID)-placebo controlled study.